Ipamorelin Nasal Sprays are strictly intended for research purposes and are not for human consumption
As of 2024, there are no published human clinical trials specifically investigating GLP-1 receptor agonists as a treatment for endometriosis
Combine an unvalidated dose with a product purchased as a "research chemical" of unverified identity, purity, and sterility, and the gap between online enthusiasm and responsible clinical practice becomes obvious
Some GLP-1 users report strong food aversions, or strong aversions to specific foods, often driven by the smell or taste
Two Forms of CJC-1295 CJC-1295 exists in two clinically relevant forms: CJC-1295 with DAC (Drug Affinity Complex): This version includes a lysine linker that allows the peptide to bind to albumin in the bloodstream, dramatically extending its half-life to approximately 6-8 days
FDA inspections have identified violations including improper equipment use, inadequate supplier vetting, and labeling issues